For residents in Lansing, East Lansing, and nearby communities seeking effective weight management solutions, our physician-led program offers personalized treatment plans featuring GLP-1 receptor agonist injections
The Gila monster, in its slow, patient way, has changed the world
For instance, the ELIXA trial investigated the impact of lixisenatide, a short-acting GLP-1RA, on 6068 patients with T2DM who had an acute coronary event within 3 months before screening
Neither medication has yet demonstrated reduced cardiovascular events in dedicated outcome trials, though these studies are ongoing
Individual factors influence bruising risk: thinner skin, lower platelet counts, blood-thinning medications (aspirin, warfarin), and certain supplements increase vulnerability